Sofinnova Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-299,691
| Closed | -$569K | – | 61 |
|
2024
Q2 | $569K | Sell |
299,691
-7,038
| -2% | -$13.4K | 0.03% | 67 |
|
2024
Q1 | $871K | Buy |
+306,729
| New | +$871K | 0.05% | 56 |
|
2022
Q3 | – | Sell |
-187,381
| Closed | -$3.61M | – | 52 |
|
2022
Q2 | $3.61M | Buy |
187,381
+87,381
| +87% | +$1.68M | 0.3% | 44 |
|
2022
Q1 | $1.29M | Buy |
+100,000
| New | +$1.29M | 0.1% | 47 |
|